Document Detail


Evaluation of liver function tests in scleroderma patients.
MedLine Citation:
PMID:  21644046     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Systemic sclerosis is a clinically heterogeneous, systemic disorder which affects the connective tissue of the skin, internal organs, and the walls of blood vessels. It is characterized by alterations of the microvasculature, disturbances of the immune system and by massive deposition of collagen and other matrix substances in the connective tissue. This study was done to evaluate the frequency of liver disease in patients with scleroderma and, secondarily, to study the frequency of infection of hepatitis B and C virus in these patients and determine frequency of serum auto-antibodies in this disease. We studied patients with scleroderma, localized or systemic, in the outpatient clinic of rheumatology and dermatology departments, at King Khalid University Hospital. As for a comparison, healthy persons coming to the clinic with the same mean age were considered as control group. Forty patients with the diagnosis of scleroderma included in this work, 35% had elevated gamma-glutamyl-transferase (γ-GT), 30% had elevated alkaline phosphatase (AP) and in 17.5%, the alanine-amino-transferase (ALT) was above the reference values. The ALT had changed to be more in scleroderma patients than in controls. Twenty percent (20%) of the patients tested positive for anti-smooth muscle antibodies (anti-SMA) and only one patient had anti-mitochondrial antibodies (AMA). There was no statistical difference between the two groups regarding antibody testing. Anti-HCV antibodies were observed in one patient, and HBsAg was detected in another scleroderma patient. There was no patient with clinically significant hepatic disease. In this study, although changes in liver enzymes in patients with scleroderma were not uncommon, there was no scleroderma patient with clinical manifestations of liver disease.
Authors:
Gehan Ibrahim Abdelrazek Salem; Awni Ali Abdulrahman
Related Documents :
3046226 - A controlled release form of madopar in parkinsonian patients with advanced disease and...
25320216 - Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data ...
21904206 - Upper gastrointestinal bleedings in patients with hereditary coagulation disorders in n...
17569226 - Meg evaluation of parkinson's diseased patients after external magnetic stimulation.
1679476 - Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis.
22277176 - Detection of preclinical body fluid retention in established heart failure patients dur...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-5
Journal Detail:
Title:  Rheumatology international     Volume:  -     ISSN:  1437-160X     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8206885     Medline TA:  Rheumatol Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Physical Medicine, Rheumatology and Rehabilitation, Assiut University Hospital, Assiut University, Assiut, Egypt, gehan_us@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A comparative analysis of serological parameters and oxidative stress in osteoarthritis and rheumato...
Next Document:  Bone morphogenetic protein receptor IB as a marker for enrichment of osteogenic precursor-like cells...